Medical News Today: How do hearing and sight influence cognitive decline?

Hearing and sight loss are tied to faster cognitive decline, so does addressing these issues slow down cognitive deterioration? New studies investigate.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Related Links:

This study shows that it seems that mental activity is as important as physical activity to preserve or increase the chances of healthy aging.” Similar studies that have looked at the link between physical or mental activity and dementia have not usually included as long an observation period as the new analysis does. Most of those studies also start with people who were much older and who were potentially already affected by different types of dementia. In her analysis, Najar adjusted for the fact that some of the women in the study might already be experiencing early signs of dementia. She also found that exercise ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Brain Source Type: news
DEMENTIA is becoming more and more common as people are living longer. There are a number of things which can increase the risk of developing vascular dementia or Alzheimer ’s disease, but how do you know if you’re at risk?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
(MedPage Today) -- Engaging in mental or physical activities dropped dementia risk 44 years later
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
Condition:   Dementia; Alzheimer, Mixed Type (Etiology) Interventions:   Dietary Supplement: Omni-Biotic Stress Repair;   Dietary Supplement: placebo Sponsor:   Medical University of Graz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Mood-boosting drug trazodone has been shown to slow neurodegenerative conditions in mice. The UK Dementia Research Institute will start the first human trials later this year.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Condition:   Dementia; Alzheimer, Mixed Type (Etiology) Interventions:   Dietary Supplement: Omni-Biotic Stress Repair;   Dietary Supplement: placebo Sponsor:   Medical University of Graz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
DiscussionPatterns of racial/ethnic disparities in dementia seen in younger older adults continue after the age of 90 years, though smaller in magnitude.
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Authors: Langbaum JB, Karlawish J, Roberts JS, Wood EM, Bradbury A, High N, Walsh TL, Gordon D, Aggarwal R, Davis P, Stowell C, Trisko L, Langlois CM, Reiman EM, Tariot PN Abstract INTRODUCTION: Recruitment for Alzheimer's disease (AD) prevention research studies is challenging because of lack of awareness among cognitively healthy adults coupled with the high screen fail rate due to participants not having a genetic risk factor or biomarker evidence of the disease. Participant recruitment registries offer one solution for efficiently and effectively identifying, characterizing, and connecting potential eligible vo...
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
Treatments offering to combat dementia and other Alzheimer's Disease-related conditions with infusions of blood from young donors were slapped Tuesday by the Food and Drug Administration, prompting at least one company to cease treatments. The statement by FDA Commissioner Scott Gottlieb shines a light on the work of a handful of companies operating in the Bay Area — including at least one in human clinical trials — but focuses on "establishments in several states" that offer plasma infusions…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
(Bloomberg) — Taking a young person’s plasma and infusing it into an older person to ward off aging — a therapy that’s fascinated some of the biggest names in Silicon Valley — has no proven clinical benefit, the Food and Drug Administration said. The agency issued a safety alert on Tuesday about the infusion of plasma from young donors for the prevention of conditions such as aging or memory loss, or for the treatment of such conditions as dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease or postā€traumatic stress disorder. “There is no pr...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Aging Bloomberg Food and Drug Administration onetime Source Type: news
More News: Alzheimer's | Dementia | Eyes | Health | Study